多变量纵向聚类在阿尔茨海默病进展研究中揭示了神经心理因素作为痴呆症预测因素
相关实验视频
Updated: May 3, 2026

06:35
Basics of Multivariate Analysis in Neuroimaging Data
Published on: July 25, 2010
17.6K
Patrizia Ribino1, Claudia Di Napoli2, Giovanni Paragliola2
1Consiglio Nazionale delle Ricerche (CNR), Istituto di Calcolo e Reti ad Alte Prestazioni, Palermo, Italy. patrizia.ribino@icar.cnr.it.
BioData mining
|March 29, 2025
概括
这项研究引入了针对阿尔茨海默病 (AD) 进展的新聚类方法,根据多种纵向特征识别出不同的患者子组. 该方法突出了早期的行为变化,可能表明认知能力下降之前的轻度行为障碍 (MBI).
科学领域:
- 神经科学是一个神经科学.
- 数据科学数据科学数据科学
- 老年学是指老年学的学科.
背景情况:
- 阿尔茨海默病 (AD) 涉及多方面的认知和行为衰退.
- 了解AD的进展需要同时分析多个纵向特征.
- 现有的方法可能无法完全捕捉随着时间的推移各种疾病标志物的相互作用.
研究的目的:
- 为多变量时间序列数据开发先进的集群算法,以分析AD进展的联合轨迹.
- 根据同时发生的纵向因子来确定不同的患者子组,这些因素表明认知能力下降.
- 为了增强对个体患者发展的理解,并提供更深入的医学洞察到AD轨迹.
主要方法:
- 为多变量时间序列数据扩展k-means集群.
- 纵向特征的联合分析,以探索同时发生的轨迹因素.
- 对OASIS-3数据集的应用,包括预处理和特征选择.
主要成果:
- 根据其纵向轨迹识别不同的患者子组.
- 揭示了特定神经心理因素在疾病进展中的重要作用.
- 确定了一个与轻度行为障碍 (MBI) 一致的独特配置,先于认知症状.
结论:
- 拟议的集群方法通过分析多个维度,为AD进展提供了更好的理解.
- 它提供了对认知衰退轨迹的更深入的医学见解,并支持个性化的患者管理.
- 突出早期行为标志物,如MBI可以改善早期检测和干预策略的AD.
相关概念视频
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Dementia
687
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
687
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35

